Testosterone gel shows promise in Phase III trial.
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D017326:Clinical Trials, Phase III as Topic; D005782:Gels; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D013739:Testosterone / Q000008:administration & dosage*; D014481:United States
D005782:Gels; D013739:Testosterone